Shares of Starpharma Holdings Limited (OTCMKTS:SPHRY – Get Free Report) were up 8.1% during mid-day trading on Thursday . The company traded as high as $0.76 and last traded at $0.76. Approximately 4,300 shares traded hands during trading, an increase of 231% from the average daily volume of 1,300 shares. The stock had previously closed at $0.70.
Starpharma Stock Up 6.0 %
The firm has a 50 day moving average price of $0.69 and a 200 day moving average price of $0.64. The company has a quick ratio of 4.58, a current ratio of 4.94 and a debt-to-equity ratio of 0.07.
Starpharma Company Profile
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom.
Recommended Stories
- Five stocks we like better than Starpharma
- The Role Economic Reports Play in a Successful Investment Strategy
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- 5 Top Rated Dividend Stocks to Consider
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for Starpharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Starpharma and related companies with MarketBeat.com's FREE daily email newsletter.
